Medical device recalls
38684 federal recalls on file. Federal recalls for medical devices — surgical equipment, monitors, diagnostic tools, implants, home health devices. Sourced from the FDA.
- 2026-02-11FDA-DeviceETAC A/SClass IIStop using Molift 2-point sling bars
A customer experienced that during assembly and load testing of the device, the bolt for mounting the lifting bar broke. Upon further investigation of this customer complaint, it became clear that the defect occurs as a result of deformation of the materials involved between the lifting bar and the arm of the device. Such deformation can lead to limited mobility in the joint, which prevents proper functionality of the equipment.
- 2026-02-11FDA-DeviceETAC A/SClass IIStop using Molift Mover 300 hoists
A customer experienced that during assembly and load testing of the device, the bolt for mounting the lifting bar broke. Upon further investigation of this customer complaint, it became clear that the defect occurs as a result of deformation of the materials involved between the lifting bar and the arm of the device. Such deformation can lead to limited mobility in the joint, which prevents proper functionality of the equipment.
- 2026-02-11FDA-DeviceETAC A/SClass IIStop using affected Molift Mover 205 lifts
A customer experienced that during assembly and load testing of the device, the bolt for mounting the lifting bar broke. Upon further investigation of this customer complaint, it became clear that the defect occurs as a result of deformation of the materials involved between the lifting bar and the arm of the device. Such deformation can lead to limited mobility in the joint, which prevents proper functionality of the equipment.
- 2026-02-11FDA-DeviceFujirebio Diagnostics, Inc.Class IIStop using Fujirebio Lumipulse β-Amyloid Controls
Customers may experience inaccurate test results by observing a higher frequency of classification in the indeterminate and positive zone and/or low specificity when compared back to FDA-cleared CSF ratio/PET imaging, due to falsely elevated positive ratio or falsely elevated indeterminate ratio results causing an incorrect classification of a patient as having amyloid pathology associated with Alzheimer s disease (positive result) and/or requiring more clinical testing of that patient (indeterminate result).
- 2026-02-11FDA-DeviceFujirebio Diagnostics, Inc.Class IIStop using Fujirebio Lumipulse calibrators
Customers may experience inaccurate test results by observing a higher frequency of classification in the indeterminate and positive zone and/or low specificity when compared back to FDA-cleared CSF ratio/PET imaging, due to falsely elevated positive ratio or falsely elevated indeterminate ratio results causing an incorrect classification of a patient as having amyloid pathology associated with Alzheimer s disease (positive result) and/or requiring more clinical testing of that patient (indeterminate result).
- 2026-02-11FDA-DeviceFujirebio Diagnostics, Inc.Class IIStop using Fujirebio Lumipulse G amyloid test cartridges
Customers may experience inaccurate test results by observing a higher frequency of classification in the indeterminate and positive zone and/or low specificity when compared back to FDA-cleared CSF ratio/PET imaging, due to falsely elevated positive ratio or falsely elevated indeterminate ratio results causing an incorrect classification of a patient as having amyloid pathology associated with Alzheimer s disease (positive result) and/or requiring more clinical testing of that patient (indeterminate result).
- 2026-02-11FDA-DeviceFujirebio Diagnostics, Inc.Class IIStop using Fujirebio pTau 217 Plasma Controls
Customers may experience inaccurate test results by observing a higher frequency of classification in the indeterminate and positive zone and/or low specificity when compared back to FDA-cleared CSF ratio/PET imaging, due to falsely elevated positive ratio or falsely elevated indeterminate ratio results causing an incorrect classification of a patient as having amyloid pathology associated with Alzheimer s disease (positive result) and/or requiring more clinical testing of that patient (indeterminate result).
- 2026-02-11FDA-DeviceFujirebio Diagnostics, Inc.Class IIStop using Fujirebio pTau 217 calibrators
Customers may experience inaccurate test results by observing a higher frequency of classification in the indeterminate and positive zone and/or low specificity when compared back to FDA-cleared CSF ratio/PET imaging, due to falsely elevated positive ratio or falsely elevated indeterminate ratio results causing an incorrect classification of a patient as having amyloid pathology associated with Alzheimer s disease (positive result) and/or requiring more clinical testing of that patient (indeterminate result).
- 2026-02-11FDA-DeviceFujirebio Diagnostics, Inc.Class IIStop using Fujirebio pTau 217 test cartridges
Customers may experience inaccurate test results by observing a higher frequency of classification in the indeterminate and positive zone and/or low specificity when compared back to FDA-cleared CSF ratio/PET imaging, due to falsely elevated positive ratio or falsely elevated indeterminate ratio results causing an incorrect classification of a patient as having amyloid pathology associated with Alzheimer s disease (positive result) and/or requiring more clinical testing of that patient (indeterminate result).
- 2026-02-11FDA-DeviceFujirebio Diagnostics, Inc.Class IIContact your lab about Fujirebio Lumipulse G test
Customers may experience inaccurate test results by observing a higher frequency of classification in the indeterminate and positive zone and/or low specificity when compared back to FDA-cleared CSF ratio/PET imaging, due to falsely elevated positive ratio or falsely elevated indeterminate ratio results causing an incorrect classification of a patient as having amyloid pathology associated with Alzheimer s disease (positive result) and/or requiring more clinical testing of that patient (indeterminate result).
- 2026-02-11FDA-DeviceMaquet Cardiopulmonary GmbhClass IICheck Maquet bubble sensor cable connections
Internal investigations have identified an issue with the durability of the connecting cable near the connection to the Venous Bubble Sensor. Excessive bending of the connecting cable can lead to full damage of the Venous Bubble Sensor or loose cable contact, which may trigger the errors Ven. bubble sensor defective or Ven. bubble sensor disconnected on the connected medical device. These errors can occur temporarily when the connecting cable is moved or permanently if the connection is fully compromised.
- 2026-02-11FDA-DeviceFUJIFILM Healthcare Americas CorporationClass IIStop using affected FUJIFILM FDR Visionary Suite units
It was found that the contacts of the electromagnetic contactors used inside the cabinet of the X-ray high-voltage generator were welded, and the current might continue to be supplied to the power supply circuit even if the power of the device is cut off. As a result, it cannot be denied that the circuit in question overheats and damages the surrounding parts. It may also cause smoke.
- 2026-02-11FDA-DeviceWilson-Cook Medical Inc.Class IICheck Wilson-Cook nasal feeding tubes for missing part
Nasal feeding tube packaged without the nasal transfer tube component.
- 2026-02-11FDA-DeviceOlympus Corporation of the AmericasClass IIStop using Olympus KD-VC411Q-0725 sphincterotome
Devices which did not undergo thermoforming could deform and lose performance.
- 2026-02-11FDA-DeviceOlympus Corporation of the AmericasClass IIStop using Olympus KD-V411M-3025 sphincterotome
Devices which did not undergo thermoforming could deform and lose performance.
- 2026-02-11FDA-DeviceOlympus Corporation of the AmericasClass IIStop using Olympus sphincterotome model KD-V411M-3020
Devices which did not undergo thermoforming could deform and lose performance.
- 2026-02-11FDA-DeviceOlympus Corporation of the AmericasClass IIStop using Olympus sphincterotome KD-401Q-0725
Devices which did not undergo thermoforming could deform and lose performance.
- 2026-02-11FDA-DeviceOlympus Corporation of the AmericasClass IIStop using Olympus sphincterotome model KD-401Q-0320
Devices which did not undergo thermoforming could deform and lose performance.
- 2026-02-11FDA-DeviceOlympus Corporation of the AmericasClass IIStop using Olympus KD-V411M-3030 sphincterotomes
Devices which did not undergo thermoforming could deform and lose performance.
- 2026-02-11FDA-DeviceOlympus Corporation of the AmericasClass IIStop using Olympus KD-V411M-1530 sphincterotome
Devices which did not undergo thermoforming could deform and lose performance.
- 2026-02-11FDA-DeviceOlympus Corporation of the AmericasClass IIStop using Olympus sphincterotome model KD-V411M-1520
Devices which did not undergo thermoforming could deform and lose performance.
- 2026-02-11FDA-DeviceOlympus Corporation of the AmericasClass IIStop using Olympus KD-401Q-0730 sphincterotomes
Devices which did not undergo thermoforming could deform and lose performance.
- 2026-02-11FDA-DeviceOlympus Corporation of the AmericasClass IIStop using Olympus sphincterotome model KD-401Q-0720
Devices which did not undergo thermoforming could deform and lose performance.
- 2026-02-11FDA-DeviceOlympus Corporation of the AmericasClass IIStop using Olympus KD-401Q-0330 sphincterotomes
Devices which did not undergo thermoforming could deform and lose performance.
- 2026-02-11FDA-DeviceOlympus Corporation of the AmericasClass IIStop using Olympus KD-411Q-0730 sphincterotome
Devices which did not undergo thermoforming could deform and lose performance.
- 2026-02-11FDA-DeviceOlympus Corporation of the AmericasClass IIStop using Olympus sphincterotome model KD-411Q-0720
Devices which did not undergo thermoforming could deform and lose performance.
- 2026-02-11FDA-DeviceOlympus Corporation of the AmericasClass IIStop using Olympus sphincterotome model KD-VC433Q-0730
Devices which did not undergo thermoforming could deform and lose performance.
- 2026-02-11FDA-DeviceOlympus Corporation of the AmericasClass IIStop using Olympus sphincterotome model KD-VC433Q-0720
Devices which did not undergo thermoforming could deform and lose performance.
- 2026-02-11FDA-DeviceOlympus Corporation of the AmericasClass IICheck Olympus sphincterotome model KD-VC412Q-0215
Devices which did not undergo thermoforming could deform and lose performance.
- 2026-02-11FDA-DeviceOlympus Corporation of the AmericasClass IIStop using Olympus sphincterotome model KD-VC411Q-0330
Devices which did not undergo thermoforming could deform and lose performance.
Get notified about new device recalls
Free weekly digest. We email when a new federal recall in this category — or anything else affecting your household — is published.
Get the Sunday Brief